Zenta Tsuchihashi

Senior Director, Translational Patient Safety, Clinical Safety & Pharmacovigilance Daiichi Sankyo

Seminars

Monday 23rd February 2026
Exploring Predictive Biomarkers for ADC Drug-Induced Pulmonary Toxicities: The Enhertu Experience
2:00 pm
  • Overviewing biomarkers for ADC drug induced pulmonary toxicities
  • Bridging non-clinical toxicology findings and clinical translational safety research
  • Case study: Assessing ILD concerns in HER2-targeted ADCs to explore how biomarkers in blood helping refine prediction and how can we monitor and treat ADC toxicities
Zenta Tsuchihashi Speaker Photo - 16th World ADC London Summit